Covered recipient · General Payments record
JUANLY NEFATLI RODRIGUEZ VELEZ
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2021–2024
$898.76
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $340.80 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $124.45 | 6 |
| GlaxoSmithKline, LLC. | $62.47 | 3 |
| Otsuka America Pharmaceutical, Inc. | $28.90 | 1 |
| Relypsa, Inc. | $23.73 | 1 |
| Novo Nordisk AS | $23.10 | 1 |
| Retrophin, Inc. | $22.21 | 1 |
| Medtronic, Inc. | $20.50 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $18.49 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.07 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117367274 | CMS |
| Amgen Inc. | $14.93 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117367276 | CMS |
| Amgen Inc. | $21.57 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111690844 | CMS |
| Amgen Inc. | $31.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111690846 | CMS |
| Amgen Inc. | $16.08 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117367278 | CMS |
| Amgen Inc. | $24.80 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111690848 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $18.49 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141507880 | CMS |
| GlaxoSmithKline, LLC. | $22.38 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115879781 | CMS |
| GlaxoSmithKline, LLC. | $20.10 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116643752 | CMS |
| GlaxoSmithKline, LLC. | $19.99 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116724536 | CMS |
| Medtronic, Inc. | $20.50 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119465083 | CMS |
| Novartis Pharmaceuticals Corporation | $16.95 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087313905 | CMS |
| Novo Nordisk Inc | $23.10 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097194890 | CMS |
| Otsuka America Pharmaceutical, Inc. | $28.90 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118970725 | CMS |
| Travere Therapeutics, Inc. | $22.21 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149912976 | CMS |
| Vifor Pharma, Inc. | $23.73 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124057897 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.